Prefrontal cortex infusion of beta‐hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant‐like effects in a rodent model of depression-Reference-Cited by-同舟云学术

Prefrontal cortex infusion of beta‐hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant‐like effects in a rodent model of depression

Published:2020-03-03 Issue:2 Volume:40 Page:157-165
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharmacol Rep

Author:

Kajitani Naofumi¹,Iwata Masaaki¹^ORCID,Miura Akihiko¹,Tsunetomi Kyohei¹,Yamanashi Takehiko¹,Matsuo Ryoichi¹,Nishiguchi Tsuyoshi¹,Fukuda Saki¹,Nagata Mayu¹,Shibushita Midori¹,Yamauchi Takahira²,Pu Shenghong¹,Shirayama Yukihiko³,Watanabe Ken⁴,Kaneko Koichi¹

Affiliation:

1. Department of Neuropsychiatry Faculty of Medicine Tottori University Yonago Japan

2. Department of Psychiatry Nara Medical University School of Medicine Kashihara Japan

3. Department of Psychiatry Teikyo University Chiba Medical Center Ichihara Japan

4. Watanabe Hospital Tottori Japan

Funder

GlaxoSmithKline foundation

SENSHIN Medical Research Foundation

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12099

Reference56 articles.

1. Stress and Depression

2. THE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION

3. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression;Duman RS;Dialogues Clin Neurosci,2009

4. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

5. The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders;Expert Opinion on Therapeutic Targets;2024-05-03

2. The NLRP3 Inflammasome as a Target for Antiinflammatory Drugs;The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response;2024-04-02

3. New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation;Journal of Neuroimmune Pharmacology;2024-02-29

4. Dietary and Metabolic Approaches for Treating Autism Spectrum Disorders, Affective Disorders and Cognitive Impairment Comorbid with Epilepsy: A Review of Clinical and Preclinical Evidence;Nutrients;2024-02-17

5. Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression;Neural Regeneration Research;2023-12-15